Latigo Biotherapeutics, Inc.: SCHEDULE 13G filed Aug 17, 2026

Form type
SCHEDULE 13G
Filing date
Aug 17, 2026
Accession number
0001346824-26-000233
Filer
Latigo Biotherapeutics, Inc. (CIK 2056611)